Sensing of bacteria: NOD a lonely job

Current Opinion in Microbiology

Volumn 10, Issue 1, 2007, Pages 62-69

  Kufer, Thomas A ^a,b   Sansonetti, Philippe J ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

BACILLUS ANTHRACIS; BIOSENSOR; HELICOBACTER PYLORI; INFLAMMATION; MOLECULAR RECOGNITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIA; HUMANS; IMMUNITY, NATURAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDOGLYCAN; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS); VERTEBRATA;

EID: 33846827092     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2006.11.003     Document Type: Review

References (64)

1. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27 (2006) 352-357
2. Kufer T.A., Fritz J.H., and Philpott D.J. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol 13 (2005) 381-388
3. Meylan E., Tschopp J., and Karin M. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
4. West A.P., Koblansky A.A., and Ghosh S. Recognition and signaling by Toll-like receptors. Annu Rev Cell Dev Biol 22 (2006) 409-437
5. Inohara N., Chamaillard M., McDonald C., and Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 74 (2005) 355-383
6. Ting J.P., and Davis B.K. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 23 (2005) 387-414
7. Meylan E., and Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 22 (2006) 561-569
8. Traub S., von Aulock S., Hartung T., and Hermann C. MDP and other muropeptides-direct and synergistic effects on the immune system. J Endotoxin Res 12 (2006) 69-85. An excellent recent overview of the biological effects of muropeptides.
9. Magalhaes J.G., Philpott D.J., Nahori M.A., Jehanno M., Fritz J., Bourhis L.L., Viala J., Hugot J.P., Giovannini M., Bertin J., et al. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep 6 (2005) 1201-1207
10. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5 (2004) 1166-1174
11. Boughan P.K., Argent R.H., Body-Malapel M., Park J.H., Ewings K.E., Bowie A.G., Ong S.J., Cook S.J., Sorensen O.E., Manzo B.A., et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem 281 (2006) 11637-11648
12. Sugawara Y., Uehara A., Fujimoto Y., Kusumoto S., Fukase K., Shibata K., Sugawara S., Sasano T., and Takada H. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 85 (2006) 524-529
13. Uehara A., Sugawara Y., Kurata S., Fujimoto Y., Fukase K., Kusumoto S., Satta Y., Sasano T., Sugawara S., and Takada H. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via Toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell Microbiol 7 (2005) 675-686
14. -/- mice. This paper shows that Nod2 is needed for cryptidin expression and control of bacterial infection in the intestine.
15. Sansonetti P.J. War and peace at mucosal surfaces. Nat Rev Immunol 4 (2004) 953-964
16. Charrier L., and Merlin D. The oligopeptide transporter hPepT1: gateway to the innate immune response. Lab Invest 86 (2006) 538-546
17. Meylan E., and Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30 (2005) 151-159
18. Abbott D.W., Wilkins A., Asara J.M., and Cantley L.C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 14 (2004) 2217-2227
19. Girardin S.E., Tournebize R., Mavris M., Page A.L., Li X., Stark G.R., Bertin J., DiStefano P.S., Yaniv M., Sansonetti P.J., and Philpott D.J. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2 (2001) 736-742
20. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J., et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 274 (1999) 14560-14567
21. da Silva C.J., Miranda Y., Austin-Brown N., Hsu J., Mathison J., Xiang R., Zhou H., Li Q., Han J., and Ulevitch R.J. Nod1-dependent control of tumor growth. Proc Natl Acad Sci USA 103 (2006) 1840-1845. This study shows that Nod1 can induce apoptosis in breast cancer epithelial cells and control tumor growth.
22. Yoo N.J., Park W.S., Kim S.Y., Reed J.C., Son S.G., Lee J.Y., and Lee S.H. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun 299 (2002) 652-658
23. Kanneganti T.D., Ozoren N., Body-Malapel M., Am A., Park J.H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440 (2006) 233-236
24. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., and Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006) 228-232
25. Martinon F., Agostini L., Meylan E., and Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 14 (2004) 1929-1934
26. Martinon F., Petrilli V., Mayor A., Tardivel A., and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237-241
27. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., Bertin J., Coyle A.J., Galan J.E., Askenase P.W., et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24 (2006) 317-327
28. Boyden E.D., and Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38 (2006) 240-244
29. Miao E.A., Alpuche-Aranda C.M., Dors M., Clark A.E., Bader M.W., Miller S.I., and Aderem A. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7 (2006) 569-575
30. Franchi L., Am A., Body-Malapel M., Kanneganti T.D., Ozoren N., Jagirdar R., Inohara N., Vandenabeele P., Bertin J., Coyle A., et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7 (2006) 576-582
31. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., and Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004) 213-218
32. Takada H., and Galanos C. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun 55 (1987) 409-413
33. ••,34] show that peptidoglycan is not recognized by TLR2.
34. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., and Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 5 (2004) 1000-1006
35. Netea M.G., Ferwerda G., de Jong D.J., Werts C., Boneca I.G., Jehanno M., Van der Meer J.W., Mengin-Lecreulx D., Sansonetti P.J., Philpott D.J., et al. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists. J Biol Chem 280 (2005) 35859-35867
36. van Heel D.A., Ghosh S., Butler M., Hunt K., Foxwell B.M., Mengin-Lecreulx D., and Playford R.J. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol 35 (2005) 2471-2476
37. Uehara A., Yang S., Fujimoto Y., Fukase K., Kusumoto S., Shibata K., Sugawara S., and Takada H. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 7 (2005) 53-61
38. Traub S., Kubasch N., Morath S., Kresse M., Hartung T., Schmidt R.R., and Hermann C. Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J Biol Chem 279 (2004) 8694-8700
39. •].
40. •] are detailed studies of the synergistic effects between TLR and NLR agonists on cytokine responses.
41. Li J., Moran T., Swanson E., Julian C., Harris J., Bonen D.K., Hedl M., Nicolae D.L., Abraham C., and Cho J.H. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 13 (2004) 1715-1725
42. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., Abraham E., Kim J.M., Yoon D.Y., Dinarello C.A., and Kim S.H. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102 (2005) 16309-16314
43. Watanabe T., Kitani A., Murray P.J., and Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5 (2004) 800-808
44. Netea M.G., Ferwerda G., de Jong D.J., Jansen T., Jacobs L., Kramer M., Naber T.H., Drenth J.P., Girardin S.E., Kullberg B.J., et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 174 (2005) 6518-6523
45. Ferwerda G., Girardin S.E., Kullberg B.J., Le Bourhis L., de Jong D.J., Langenberg D.M., van Crevel R., Adema G.J., Ottenhoff T.H., Van der Meer J.W., et al. NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 1 (2005) 279-285. This study provides evidence that both TLR and NLR signalling is needed for bacterial recognition.
46. Rosenstiel P., Fantini M., Brautigam K., Kuhbacher T., Waetzig G.H., Seegert D., and Schreiber S. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124 (2003) 1001-1009
47. Takahashi Y., Isuzugawa K., Murase Y., Imai M., Yamamoto S., Iizuka M., Akira S., Bahr G.M., Momotani E., Hori M., et al. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J Vet Med Sci 68 (2006) 471-478
48. McDonald C., Chen F.F., Ollendorff V., Ogura Y., Marchetto S., Lecine P., Borg J.P., and Nunez G. A role for Erbin in the regulation of NOD2-dependent NF-kappa B signaling. J Biol Chem 280 (2005) 40301-40309
49. Weichart D., Gobom J., Klopfleisch S., Hasler R., Gustavsson N., Billmann S., Lehrach H., Seegert D., Schreiber S., and Rosenstiel P. Analysis of NOD2-mediated proteome response to muramyl dipeptide in HEK293 cells. J Biol Chem 281 (2006) 2380-2389
50. Takada H., Yokoyama S., and Yang S. Enhancement of endotoxin activity by muramyldipeptide. J Endotoxin Res 8 (2002) 337-342
51. Masumoto J., Yang K., Varambally S., Hasegawa M., Tomlins S.A., Qiu S., Fujimoto Y., Kawasaki A., Foster S.J., Horie Y., et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 203 (2006) 203-213
52. Damiano J.S., Oliveira V., Welsh K., and Reed J.C. Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem J 381 (2004) 213-219
53. •]
54. Hysi P., Kabesch M., Moffatt M.F., Schedel M., Carr D., Zhang Y., Boardman B., von Mutius E., Weiland S.K., Leupold W., et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 14 (2005) 935-941. These are the first papers to describe functional implications of Nod splice-variants.
55. Saleh M., Vaillancourt J.P., Graham R.K., Huyck M., Srinivasula S.M., Alnemri E.S., Steinberg M.H., Nolan V., Baldwin C.T., Hotchkiss R.S., et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429 (2004) 75-79
56. Barnich N., Hisamatsu T., Aguirre J.E., Xavier R., Reinecker H.C., and Podolsky D.K. GRIM-19 interacts with NOD2 and serves as down-stream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem 280 (2005) 40301-40309
57. Kufer T.A., Kremmer E., Banks D.J., and Philpott D.J. Role for Erbin in bacterial activation of Nod2. Infect Immun 74 (2006) 3115-3124
58. Chen C.M., Gong Y., Zhang M., and Chen J.J. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J Biol Chem 279 (2004) 25876-25882
59. Li L., Bin L.H., Li F., Liu Y., Chen D., Zhai Z., and Shu H.B. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways. J Cell Sci 118 (2005) 555-563
60. Sarkar A., Duncan M., Hart J., Hertlein E., Guttridge D.C., and Wewers M.D. ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 176 (2006) 4979-4986
61. Pan Q., Kravchenko V., Katz A., Huang S., Ii M., Mathison J.C., Kobayashi K., Flavell R.A., Schreiber R.D., Goeddel D., et al. NF-kappa B-inducing kinase regulates selected gene expression in the Nod2 signaling pathway. Infect Immun 74 (2006) 2121-2127. This study shows that Nod2 is able to activate the alternative NF-κB pathway.
62. Barnich N., Aguirre J.E., Reinecker H.C., Xavier R., and Podolsky D.K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol 170 (2005) 21-26
63. Oda K, Kitano H: A comprehensive map of the Toll-like receptor signaling network. Mol Syst Biol 2006, 2:2006.0015. Epub 2006 Apr 18.
64. Gurcel L., Abrami L., Girardin S., Tschopp J., and van der Goot F.G. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126 (2006) 1135-1145. This paper provides evidence for a non-redundant function of both Nalp3 and Ipaf in sensing potassium efflux mediated by pore-forming toxins in host cells.